Chiropractors in Ellenton, FL Accepting Medicare
9 Chiropractors found. Showing 1 - 9
 Manatee Medical Massage & Chiropractic, Inc. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2823 Us Highway 301 N, Suite 3, Ellenton, FL 34222 Phone: 941-723-1908 Fax: 941-723-1303 |
 Dr. Andrew David Jepsen, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 5811 28th St E Unit 208, Ellenton, FL 34222 Phone: 239-272-7078 |
Manatee Chiropractic & Wellness Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7216 Us Highway 301 N, Suite #110, Ellenton, FL 34222 Phone: 941-462-2663 |
 Angela Van Waes, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 6312 Us 301 N, Ellenton, FL 34222 Phone: 941-304-2054 |
Dr. Curtis Matthew Reynolds, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 7915 U.s. 301 N. Unit 103, Ellenton, FL 34222 Phone: 941-479-4999 Fax: 941-479-4998 |
Dr. Jacqueline Figueroa, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 6312 Us Highway 301 N, Ellenton, FL 34222 Phone: 941-524-1833 |
Premier Family Chiropractic, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 6312 Us Highway 301 N, Ellenton, FL 34222 Phone: 941-524-1833 |
Dr. Susan M Schoonmaker, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7032 Us Hwy 301 North, Simple Relief Wellness Center, Ellenton, FL 34222 Phone: 727-709-5636 |
Elite Integrated Medical Centers Chiropractor Medicare: Medicare Enrolled Practice Location: 7915 Us 301 N Ste 103, Ellenton, FL 34222 Phone: 941-479-4999 Fax: 941-479-4998 |
News Archive
Eli Lilly acquires SGX Pharmaceuticals
Eli Lilly and Company has announced that it has completed the acquisition of SGX Pharmaceuticals, Inc. (Public, NASDAQ:SGXP), a San Diego-based biotechnology company focused on drug discovery and development in the area of oncology.
New agreement to expand scope of research project to evaluate MCT-485 for primary liver cancer
MultiCell Technologies, Inc. is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.
Alzheimer's Association, SNMMI publish appropriate use criteria for brain amyloid imaging with PET
Only recently has it become possible to create high-quality images of the brain plaques characteristic of Alzheimer's disease in living people through positron emission tomography (PET). Even so, questions remain about what can be learned from these PET images and which people should have this test.
Update on Enobia Pharma's effort to develop ENB-0040 for treating HPP patients
Enobia Pharma today provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of hypophosphatasia. Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.
Al Amal Hospital in Qatar commences treatment with Varian's RapidArc radiotherapy
One of the leading cancer centers in the Middle East has become among the first in the region to introduce fast and efficient RapidArc® radiotherapy treatments from Varian Medical Systems. Al Amal Hospital in Doha, Qatar, has treated nine brain cancer, prostate cancer and head & neck cancer patients with RapidArc since commencing treatments in early May, and it now plans to roll out the technology for many more indications.
› Verified 4 days ago
Chiropractors
Physical Therapists
Podiatrists
Audiologists
Speech-Language Pathologists